129-18-0,
Phenylbutazone sodium,
SODIUM 4-BUTYL-3,5-DIOXO-1,2-DIPHENYLPYRAZOLIDIN-4-IDE,
Sodium phenylbutazone,
UNII-189M850I32,
189M850I32,
Butazolidine sodium,
4-Butyl-1,2-diphenylpyrazolidine-3,5-dione, sodium salt,
Ambene (TN),
GP26872,
Diphenyldioxobutylpyrazolidine-butazolidine-sodium,
Sodium salt of phenylbutazone,
4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione sodium salt,
DTXSID70926268,
KS-00000O0P,
EINECS 204-935-7,
AK393759,
AS-72188,
FT-0689452,
D08364,
3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidin sodium,
Q27251987,
3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-, monosodium salt,
3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-, ion(1-), sodium (1:1),
Sodium butazolidine,
butazolidinesodium,
sodiumphenylbutazone,
Phenylbutazone sodium salt,
AN-23035,
3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidinsodium,
5-pyrazolidinedione,4-butyl-1,2-diphenyl-monosodiumsalt,
4-BUTYL-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE SODIUM,
sodium 4-butyl-1,2-diphenyl-pyrazolidin-4-ide-3,5-dione,